A research team led by St. Jude Children’s Research Hospital scientists has identified a potential new target for treatment of the childhood eye tumor retinoblastoma. Their work also settles a scientific debate by showing the cancer’s cellular origins …
Author: Medical News Today
Construction Of Moving Objects By The Visual System
Although our eyes record the word as millions of pixels, “the visual system is fantastic at giving us a world that looks like objects, not pixels,” says Northwestern University psychologist Steven L. Franconeri. It does this by grouping areas of the wo…
Scripps Research Scientist Identifies Critical Role For Night Blindness Gene
A scientist from the Florida campus of The Scripps Research Institute has determined how a particular gene makes night vision possible The study, which was published in the August 10, 2011 edition of The Journal of Neuroscience, focuses on a gene call…
AFER Announces Two New Research Fellowships In AMD And Dry Eye For Young Researchers
For the first time, the ARVO Foundation for Eye Research (AFER) will support AMD and dry eye research projects with two new fellowships for investigators under age 45. Traditionally, AFER’s awards programs have recognized researchers’ accomplishments r…
U. Iowa Research Team Finds New Genetic Cause Of Blinding Eye Disease
Combining the expertise of several different labs, University of Iowa researchers have found a new genetic cause of the blinding eye disease retinitis pigmentosa (RP) and, in the process, discovered an entirely new version of the message that codes fo…
JCI Online Early Table Of Contents: August 8, 2011
Drug development in the blink of an eye The development of drugs for brain-related conditions is not an efficient process; only 8% of candidate drugs that enter clinical trials gain FDA approval. A key reason for this low success rate is a lack of pre…
Age-Related Macular Degeneration May Be Easier To Predict Thanks To New Risk Assessment Model
According to a report published Online First by Archives of Ophthalmology, one of the JAMA/Archives journals, a new risk assessment model may help predict the development of advanced age-related macular degeneration. The article’s background informati…
Glaucoma Progression Can Be Detected Earlier With More Frequent Visual Testing
According to a report published Online First by Archives of Ophthalmology, one of the JAMA/Archives journals, frequent visual field testing may be linked to earlier detection of the condition’s progression in patients with glaucoma. Background informa…
New Tactile Technology May Provide New Means Of Communication For The Blind
A new tactile technology developed at Disney Research, Pittsburgh (DRP), called Surround Haptics, makes it possible for video game players and film viewers to feel a wide variety of sensations, from the smoothness of a finger being drawn against skin …
Discovery Of Potential New Eye Tumor Treatment
New research from a team including several Carnegie scientists demonstrates that a specific small segment of RNA could play a key role in the growth of a type of malignant childhood eye tumor called retinoblastoma. The tumor is associated with mutation…
With Diabetes, Untreated Depression Can Lead To Serious Eye Disease
Patients with diabetes who also suffer from depression are more likely to develop a serious complication known as diabetic retinopathy, a disease that damages the eye’s retina, a five-year study finds…
Ophthalmologist Helps Develop Device For Monitoring Degenerative Eye Disease
An ophthalmologist at UT Southwestern Medical Center has helped create a convenient device that lets patients who have a degenerative eye disease better track vision changes. With the hand-held digital device, called myVisionTrack, patients can now per…
Finding It Harder To See The Wood For The Trees: Changes In Attention And Visual Perception Are Correlated With Aging
When looking at a picture of many trees, young people will tend to say: “This is a forest”. However, the older we get, the more likely we are to notice a single tree before seeing the forest. This suggests that the speed at which the brain processes th…
For Patients With Inherited Blindness, Drug Shown To Improve Sight
A clinical trial led by Newcastle University shows that the drug, idebenone (Catena®), improved the vision and perception of colour in patients with Leber’s Hereditary Optic Neuropathy (LHON). The inherited condition means patients, who can see normal…
Retinal Cells Thoughts To Be The Same Are Not, Biologist Says
The old adage “Looks can be deceiving” certainly rings true when it comes to people. But it is also accurate when describing special light-sensing cells in the eye, according to a Johns Hopkins University biologist…
R-Tech Ueno: Protocol Amendment Of A Phase I Clinical Study Of RK-023 For The Treatment Of Hypotrichosis Of The Eyelashes
R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below…
New Study Finds Images Placed In Front Of Smartphone Screen Increase Visual Discomfort
Several reports indicate that prolonged viewing of mobile devices and other stereo 3D devices leads to visual discomfort, fatigue and even headaches. According to a new Journal of Vision study, the root cause may be the demand on our eyes to focus on t…
Inotek Pharmaceuticals To Expand Phase 2 Clinical Trial In Glaucoma Based On Promising Preliminary Results
Inotek Pharmaceuticals Corp., a leader in the development of innovative medicines to address significant diseases of the eye, today announced that the Company has successfully completed the first two of three stages of a multiple-dose Phase 2b clinical…
Pfizer Limited Withdraws Its Application For An Extension Of The Indication For Macugen (Pegaptanib Sodium), Europe
The European Medicines Agency has been formally notified by Pfizer Limited of its decision to withdraw its application for an extension of the therapeutic indication for the centrally authorised medicine Macugen (pegaptanib sodium), 0.3 mg solution for…
Charity Calls For Action On Home Safety For People With Sight Loss
People with sight loss are at risk in their own homes because of a lack of home safety services that could protect them, says a new study by sight loss charity, Thomas Pocklington Trust (1)…